PMC:7600245 / 34856-34966
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T135 | 85-88 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T527 | 48-52 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T528 | 91-100 | Chemical | denotes | aspartate | http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T256 | 0-110 | Sentence | denotes | Atazanavir (Figure 6) is another antiretroviral drug that competitively inhibits the HIV-1 aspartate protease. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1055 | 85-90 | Species | denotes | HIV-1 | Tax:11676 |
| 1060 | 0-10 | Chemical | denotes | Atazanavir | MESH:D000069446 |
| 1061 | 91-100 | Chemical | denotes | aspartate | MESH:D001224 |